Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

87,917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.
Shi ZD, Hao L, Han XX, Wu ZX, Pang K, Dong Y, Qin JX, Wang GY, Zhang XM, Xia T, Liang Q, Zhao Y, Li R, Zhang SQ, Zhang JH, Chen JG, Wang GC, Chen ZS, Han CH. Shi ZD, et al. Among authors: zhao y. Mol Cancer. 2022 Feb 7;21(1):37. doi: 10.1186/s12943-022-01517-9. Mol Cancer. 2022. PMID: 35130920 Free PMC article.
Identification and analysis of microRNA editing events in recurrent bladder cancer based on RNA sequencing: MicroRNA editing level is a potential novel biomarker.
Qin JX, Liu X, Wang XL, Wang GY, Liang Q, Dong Y, Pang K, Hao L, Xue L, Zhao Y, Hu ZX, Li R, Lv Q, Chao L, Meng FL, Shi ZD, Han CH. Qin JX, et al. Among authors: zhao y. Front Genet. 2022 Sep 19;13:984279. doi: 10.3389/fgene.2022.984279. eCollection 2022. Front Genet. 2022. PMID: 36199571 Free PMC article.
87,917 results
You have reached the last available page of results. Please see the User Guide for more information.